Lurbinectedin as second-line treatment for patients with small-cell lung cancer: a single-arm, open-label, phase 2 basket trial-Reference-Cited by-同舟云学术

Lurbinectedin as second-line treatment for patients with small-cell lung cancer: a single-arm, open-label, phase 2 basket trial

Published:2020-05 Issue:5 Volume:21 Page:645-654
ISSN:1470-2045
Container-title:The Lancet Oncology
language:en
Short-container-title:The Lancet Oncology

Author:

Trigo José,Subbiah Vivek,Besse Benjamin,Moreno Victor,López Rafael,Sala María Angeles,Peters Solange,Ponce Santiago,Fernández Cristian,Alfaro Vicente,Gómez Javier,Kahatt Carmen,Zeaiter Ali,Zaman Khalil,Boni Valentina,Arrondeau Jennifer,Martínez Maite,Delord Jean-Pierre,Awada Ahmad,Kristeleit Rebecca,Olmedo Maria Eugenia,Wannesson Luciano,Valdivia Javier,Rubio María Jesús,Anton Antonio,Sarantopoulos John,Chawla Sant P,Mosquera-Martinez Joaquín,D'Arcangelo Manolo,Santoro Armando,Villalobos Victor M,Sands Jacob,Paz-Ares Luis

Publisher

Elsevier BV

Subject

Oncology

Reference28 articles.

1. Small-cell lung cancer (SCLC): ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up;Früh;Ann Oncol,2013

2. First-line atezolizumab plus chemotherapy in extensive-stage small-cell lung cancer;Horn;N Engl J Med,2018

3. Paz-Ares L, Chen Y, Reinmuth N, et al. Overall survival with durvalumab plus etoposide-platinum in first-line extensive-stage SCLC: results from the Caspian study. World Conference on Lung Cancer (IASLC); Barcelona, Spain; Sept 7–10, 2019 (abstr PL02.11).

4. Topotecan versus cyclophosphamide, doxorubicin, and vincristine for the treatment of recurrent small-cell lung cancer;von Pawel;J Clin Oncol,1999

5. Phase II comparator study of oral versus intravenous topotecan in patients with chemosensitive small-cell lung cancer;von Pawel;J Clin Oncol,2001

Cited by 290 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Real-world comparison of chemo-immunotherapy and chemotherapy alone in the treatment of extensive-stage small-cell lung cancer;Respiratory Medicine and Research;2024-11

2. The Use of Lurbinectedin for the Treatment of Small Cell and Neuroendocrine Carcinoma of the Prostate;Clinical Genitourinary Cancer;2024-10

3. Combining Response and Toxicity Data to Implement Project Optimus;Journal of Clinical Oncology;2024-09-11

4. Phase Ib/II study on the safety, tolerability, and preliminary efficacy of pegylated irinotecan (JK1201I) as second‐line monotherapy for patients with small‐cell lung cancer;Cancer Medicine;2024-09

5. Phase I/II trial of plinabulin in combination with nivolumab and ipilimumab in patients with recurrent small cell lung cancer (SCLC): Big ten cancer research consortium (BTCRC-LUN17-127) study;Lung Cancer;2024-09